Bhatia N, Vasquez JG, Schenkel B, Heim J. Patient satisfaction with tildrakizumab treatment in a Phase 4 real-world study of tildrakizumab in patients with moderate-to-severe plaque psoriasis. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.3];7(2):s134. Available from: https://jofskin.org/index.php/skin/article/view/2004